ArticleJournal of pharmaceutical sciences2024

Integrated PK/PD Modeling Relates Smoothened Inhibitor Biomarkers to The Heterogeneous Intratumor Disposition of Cetuximab in Pancreatic Cancer Tumor Models.

Jun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.